The 20% discount pricing and restricted-share structure suggest the company needed capital urgently. Monitor for additional cash needs or further dilutive raises in coming quarters, as $555K is modest for a development-stage antimicrobial company.
Price Chart
Executive Summary
Pure Bioscience raised $555,000 in a private placement, issuing 10,183,486 shares at $0.0545 per share to director Tom Y. Lee and his affiliates. The dilutive capital raise signals cash needs for a micro-cap company, though the sole insider participation provides a modest vote of confidence.
Key Financial Metrics
Key Facts
- Closed private placement on October 15, 2026, raising $555,000
- Issued 10,183,486 shares at $0.0545 per share
- Sole investor was director Tom Y. Lee and his affiliates
- Net proceeds expected to be approximately $555,000
- Proceeds for general corporate purposes, R&D, working capital
- Shares issued under Section 4(a)(2) and Rule 506 as restricted securities
- Per Share Purchase Price equals 80% of market price on closing
Financial Impact
Dilution of approximately 10.2M new shares (exact pre-offering share count not disclosed in filing); $555K gross proceeds at a 20% discount to market price
Risk Factors
- Further dilution if additional capital raises are needed
- Micro-cap liquidity risk; stock may face selling pressure from the restricted shares once eligible for resale under Rule 144
- No new business catalysts disclosed alongside the financing
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-047762 |
| Document: form8-k.htm | 0001493152-26-047762 |
| Document: 0001493152-26-047762-index-headers.html | 0001493152-26-047762 |
| Document: 0001493152-26-047762-index.html | 0001493152-26-047762 |
| Document: 0001493152-26-047762.txt | 0001493152-26-047762 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $0.0800 $0.0800 | · 0.00% | ▼ −1.18% | $0.0900 (−12.50%) |
Jun 15, 2026 19w ago | 8-K | $0.0600 $0.0800 | ▲ +33.33% | ▲ +34.58% | $0.0900 (+50.00%) |
May 5, 2026 24w ago | 8-K | $0.0700 $0.0700 | · 0.00% | ▼ −0.33% | $0.0900 (−28.57%) |
Mar 17, 2026 32w ago | 8-K | $0.0800 $0.0800 | · 0.00% | ▲ +1.40% | $0.0900 (+12.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers